Infection risk in atopic dermatitis patients treated with biologics and <scp>JAK</scp> inhibitors: <scp>BioDay</scp> results
This cohort study demonstrated an increased risk of infection during JAKi treatment compared to dupilumab for moderate-to-severe AD. These findings enhance understanding of the differential infection risk with targeted therapies in AD, aiding tailored treatment choices that consider patient-specific risks such as prior skin infections.
Authors
- Celeste M. Boesjes (ORCID: https://orcid.org/0000-0002-3371-6414)
- Marijke Kamsteeg (ORCID: https://orcid.org/0000-0002-1389-2971)
- Simone Stadhouders‐Keet
- Marjolein S. de Bruin-Weller (ORCID: https://orcid.org/0000-0002-1249-6993)
- Klaziena Politiek (ORCID: https://orcid.org/0000-0001-6475-6876)
- Francine C. van Erp (ORCID: https://orcid.org/0000-0002-2209-5608)
- Laura Loman (ORCID: https://orcid.org/0000-0003-2731-9284)
- Anneke M. T. van Lynden‐van Nes
- Wouter R. H. Touwslager
- Lian F. van der Gang (ORCID: https://orcid.org/0000-0002-7981-7771)
- Marlies de Graaf (ORCID: https://orcid.org/0000-0001-9004-5111)
- Annebeth Flinterman (ORCID: https://orcid.org/0000-0002-8655-0497)
- Nicolaas P. A. Zuithoff (ORCID: https://orcid.org/0000-0002-4441-1448)
- Berit Velstra
- Antoni Gostyński (ORCID: https://orcid.org/0000-0002-1091-2914)
- Inge Marjet Haeck
- Marie L. A. Schuttelaar (ORCID: https://orcid.org/0000-0002-0766-4382)
- Shiarra M. Stewart
- Albert J. Oosting
- Wianda A. Christoffers
- Octavian I. Bacoș‐Cosma (ORCID: https://orcid.org/0009-0006-2731-4562)
- Lisette Berntsen‐Zandbergen
- Keneshka Atash
Institutions
- University Medical Center Groningen (NL)
- Radboud University Nijmegen (NL)
- Utrecht University (NL)
- Catharina Ziekenhuis (NL)
- Medisch Centrum Leeuwarden (NL)
- Radboud University Medical Center (NL)
- University Medical Center Utrecht (NL)
- Reinier de Graaf Hospital (NL)
- Spaarne Ziekenhuis (NL)
- St. Antonius Ziekenhuis (NL)
- Diakonessenhuis hospital (NL)
- IJsselland Ziekenhuis (NL)
- Haga Hospital (NL)
- Isala (NL)
- Tergooi (NL)
- Meander Medisch Centrum (NL)
- Spaarne Gasthuis (NL)
Publication Details
- Journal
- Journal of the European Academy of Dermatology and Venereology
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1111/jdv.20674
- Citations
- 16
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 32.08
Funders
- Eli Lilly and Company
- Pfizer
- Sanofi
- Regeneron Pharmaceuticals
- LEO Pharma